09:51 AM EST - Protox Therapeutics Inc. : reported first-quarter net and comprehensive loss of $2.3 million or $0.03 per share, compared to net and comprehensive loss of $2.0 million or $0.03 per share last year. The $300,000 increase in net loss over 2008 Q1 is primarily driven by an increase in research and development costs as the company's programs mature. The company earned interest income of $32,000, compared to $88,000 in 2008 Q1 comparative period. The company noted that interest income and investment returns have declined as a result of lower balances and lower returns available in the market. Protox Therapeutics Inc.
shares T.PRX are trading even at $0.28.
